📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reply to Suissa and Ariel: The FULFIL Trial. (2018)

First Author: Lipson DA

Attributed to: Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201709-1831le

PubMed Identifier: 28950068

Publication URI: http://europepmc.org/abstract/MED/28950068

Type: Journal Article/Review

Volume: 197

Parent Publication: American journal of respiratory and critical care medicine

Issue: 4

ISSN: 1073-449X